News

Tobacco used to create new cancer vaccine

A new cancer vaccine made from genetically engineered tobacco leaves has been found safe in a small, early-stage trial. The vaccine also spurred the immune systems of 11 out of 16 volunteers in the

HIV trial scrapped; FDA: Gardasil safe and effective;

Vaccine Research Government officials have scrapped plans for a major human trial of a new HIV vaccine, still convinced that there is considerable basic research work that needs to be done before

U.K. expects superbug vaccines within 10 years

The UK's chief medical officer is predicting that new vaccines will be available within five to 10 years that can protect hospital patients against deadly superbugs that kill thousands of people

Alzheimer’s vax skirts deadly side effects

Scientific American is reporting on the successful advance of a preclinical Alzheimer's vaccine that combines small amounts of amyloid beta and interleukin-4, which is delivered in an inactivated

Vical reports breakthrough with bird flu vaccine

San Diego- based Vical is reporting early-stage success with a new bird flu vaccine that relies on engineered bacteria to produce genes of the H5N1 virus. The DNA is combined with an adjuvant in a

Brain cancer vaccine a success in mid-stage trial

An experimental dendritic cell vaccine for glioblastoma multiforme--a lethal brain cancer--has demonstrated a successful immune response in a key study. And following a vaccination with chemotherapy

Medicago ponders new vaccine plant; police win vaccine security grant; DynPort and Quintiles win $32M contract

Vaccine Market Canada's Medicago is considering a new joint venture to build a bird flu vaccine plant in France.

CDC details side effects reported on Gardasil

The CDC says there have been about 8,000 reported incidents of adverse effects due to Gardasil vaccinations in the U.S. More than 11 million doses of Gardasil were distributed last year. The most

Genocea tackles next-gen pneumococcus vaccine

Xconomy's Luke Timmerman profiles the work of Genocea Biosciences, which is developing a low-cost, next-gen pneumococcus vaccine that can outperform the blockbuster Prevnar. Seattle-based PATH has

GeoVax readies mid-stage AIDS vaccine trial

Atlanta-based GeoVax Labs is planning to launch a mid-stage study of its AIDS vaccine this fall. The Emory University spin-off says that the NIH study would recruit 225 volunteers to help test the

Emergent accuses biotech execs of wrecking buyout pact

Rockville, MD-based Emergent BioSolutions has filed suit against Protein Sciences, saying the vaccine developer never planned to follow through on a planned $75 million acquisition agreement.

Health officials call for adult vaccine campaign; Could tomatos hold Alzheimer's vaccine key?;

Vaccine Market Public health officials in the U.S. say the country needs to develop a national program that highlights the need for adult vaccines that is as effective as the campaign for childhood

Pediatricians get tough with vaccine doubters

The American Academy of Pediatrics say that more and more parents are resisting the vaccinations that are recommended for their children, and they're mounting a promotional campaign in an attempt to

Combo vaccines endorsed by federal advisory panel

In a move that should make it easier for millions of children in the U.S. to get their recommended vaccinations, a federal vaccine advisory panel has endorsed two new combination vaccinations.

Glaxo ready to wait for late-stage Cervarix data

GlaxoSmithKline now says it will wait for the completion of a late-stage trial of its cervical cancer vaccine Cervarix before answering the FDA's questions about the therapy. That will push back any

Poland investigates deaths of homeless in vaccine trial

Polish officials are investigating the deaths of a number of homeless people who were recruited to take part in a clinical trial of a new avian flu vaccine trial. According to some of the officials,

Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;

Vaccine Research VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter.

Wall Street shrugs off FDA’s Gardasil rejection

Many Wall Street analysts greeted the FDA's decision to reject Merck's bid to expand the use of Gardasil to 27 to 45-year-old women with a yawn. For many on Wall Street, the key market for the

Merck's rotavirus vaccine makes big impact

A new report by the CDC concludes that Merck's new rotavirus vaccine has made a major impact on the disease in the last two years. RotaTeq, designed to prevent diarrhea and vomiting in children, has

Gates and GAVI gear up global vaccine initiative

The Global Alliance for Vaccines and Immunization, which is backed by a host of international health groups and the Gates Foundation, is preparing a huge new initiative to vaccinate millions of